Patients across the nation are filing lawsuits against pharmaceutical company Gilead Sciences, claiming that Atripla, along with the company’s other TDF-based medications, cause severe damage to the kidneys and bones. Plaintiffs argue they suffered complications from bone density loss and kidney injuries after taking the blockbuster HIV medication, and that Gilead knew of these risks yet failed to caution prescribing doctors or the public at large.
If you believe you may have grounds for pursuing an Atripla lawsuit against Gilead Sciences, we encourage you to speak with HIV Litigation Attorneys™ about your rights to compensation. While litigation can never erase the needless pain and suffering caused by dangerous or defective products, it can lessen the financial hardships of lost income and hospital expenses while achieving some measure of justice.
Our firm is responsible for bringing the very first lawsuits against Gilead regarding tort injuries from HIV medications and our talented attorneys are familiar with the defense strategies commonly employed by Big Pharma. We have expertise handling mass torts, multi-district litigation, personal injury claims, and class actions, and understand the disruptive and debilitating nature of Atripla side effects.
What is Atripla?
Atripla is a three-drug combination of efavirenz (EFV), a nonnucleoside reverse transcriptase inhibitor, emtricitabine (FTC) and tenofovir disoproxil fumarate (TDF), both HIV-1 nucleoside analog reverse transcriptase inhibitors. It is a potent once-a-day antiretroviral treatment for HIV-1 that is taken alone or as part of an HIV treatment protocol. Atripla is manufactured by Gilead Sciences, a biopharmaceutical company based in Foster City, California.
Atripla was one of the first once-daily HIV treatment regimen to hit the U.S. market and quickly became one of the most commonly prescribed HIV drugs after it was FDA approved in 2006. The active components in Atripla interfere with enzymes that cause HIV-infected cells to duplicate, slowing the viral spread in the body. According to Gilead Sciences, Atripla doesn’t cure HIV, but it can help reduce the HIV viral load significantly, so it is undetectable.
Unfortunately, Atripla can cause serious side effects, some of which are at the heart of ongoing litigation. All medications carry some risk of complications and adverse reactions, but it is up to the drug manufacturer to test their products and warn consumers about potential side effects.
Atripla Associated with Bone and Kidney Injuries
In clinical studies on animals and humans exposed to tenofovir disoproxil fumarate, subjects had a noted reduction in bone density. Thinner, weaker bones were reported in the spine and elsewhere. Thinner bones are at a much greater risk for fractures, even with minor trauma. Patients who take Atripla for the long-term treatment of HIV are now taking legal action against Gilead after suffering bone problems including:
- Loss of bone density (osteopenia)
- Bone fractures
Researchers believe that bone loss associated with tenofovir disoproxil fumarate is linked to kidney dysfunction caused by the TDF drug, which prevents the kidneys from returning bone-building nutrients back to the blood.
In addition to Atripla failure-to-warn and design defect cases, HIV Litigation Attorneys is also investigating claims arising from kidney problems attributed to the drug. If you have experienced declining kidney function, or are suffering from chronic kidney disease, you may have a viable claim for compensation. Our legal team takes great pride in representing those injured by HIV drugs, and does not shy away from complicated litigation.
Atripla Lawsuit – Potential Compensation
If you were harmed by Atripla side effects, contact HIV Litigation Attorneys to discuss your situation and eligibility for seeking legal compensation. Pending lawsuits against Gilead Sciences allege that the biopharmaceutical company deceptively marketed unreasonably dangerous TDF medications and intentionally stalled the development of a better and much safer tenofovir drug until the existing patent ran out.
If found liable for manufacturing defects, strict product liability, failure to warn, or other causes of action, Gilead may be forced to compensate plaintiffs for their economic and non-economic damages.
Whether settled out of court or tried before a jury, a lawsuit can seek damages for:
- Past, current and future medical bills
- Lost wages
- Loss of earning capacity
- Pain and suffering
- Emotional distress such as anxiety, fear and sleep loss
- Loss of enjoyment of life
- Loss of consortium
- Burial and funeral expenses in the event of wrongful death
- Punitive damages (awarded to punish a defendant and deter similar actions)
- Interest & legal fees
A successful lawsuit can not only achieve peace of mind for the plaintiff, but also holds reckless drug makers accountable for breaching their legal duty and endangering patients.
Explore Your Options for Legal Recourse
If you are facing health complications or injuries after taking Gilead’s Atripla, we are here to help. We invite you to contact HIV Litigation Attorneys™ to discuss your legal options. There is a time limit for how long you have to file a lawsuit, so don’t delay in reaching out to our experienced lawyers. We are taking claims throughout the country and are proud to offer tenacious advocacy on a contingent-fee basis.
- POZ, New Lawsuits Against Gilead Over Its HIV Med Tenofovir
- US Department of Health and Human Services, Efavirenz / Emtricitabine / Tenofovir Disoproxil Fumarate Brand Name Atripla
- Gilead, Atripla Patient Information